Lymphoedema after mastectomy for breast cancer: Importance of supportive care

Ay, Aybala A; Kutun, Suat; Çetin, Abdullah

doi:10.7196/sajs.1908

Cited by 5 publications

(10 citation statements)

References 17 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Variations in the timing or the onset of cancer related lymphedema ranged from three months to over ve years post diagnosis and treatment. The type of management received by women with cancer related lymphedema included: lymphatic drainage (42), physiotherapeutic modalities such as care for the affected limb, home exercises and self-lymphatic drainage (24,26,34), hormonal therapy (51) and neo-adjuvant therapy including radiotherapy and chemotherapy (25,31).…”

Section: Resultsmentioning

confidence: 99%

“…Another study (23) which examined the upper extremity disorders among breast cancer women undergoing surgery measured lymphedema as circumferential measurement difference ≥1.5 cm in the affected limb. There was only one large population study involving Turkish women with breast cancer (n=5064), which used a cut-off difference of ≥5 cm in the affected limb as a diagnosis for lymphedema (34). All Turkish studies (n=7) measured arm lymphedema by the circumferential method, while the Brazilian (n=3) (24,26,30) and Indian (n=2) (46, 47) studies used patients' self-reports.…”

Section: Synthesis Arm Lymphedema Following Breast Cancer Treatmentmentioning

confidence: 99%

“…Incidence of arm lymphedema following breast cancer treatment Eleven (11) studies reported incidence of unilateral arm lymphedema (20,21,24,34,37,41,42,(45)(46)(47)(48), while one study reported lymphedema of both arm and leg (20). The follow up periods varied among studies from 6 months to over 5 years post-cancer treatment.…”

Section: [Insert Figures 2 and 3]mentioning

confidence: 99%

“…[Insert Figure 4] Risk factors of lymphedema following breast cancer treatment Ten of the 11 studies reporting on lymphedema risk factors, focused on the risk of developing arm lymphedema following breast cancer treatment (21, 31, 34, 38, 41-43, 45, 48, 52). One study (34) reported that individuals with body mass index (BMI) of ≥30 were 6.64 times more likely to develop arm lymphedema than those with BMI ≤17.9. The risk of developing arm lymphedema among breast cancer women with BMI ≥25 ranges from the odds ratio (OR) of 1.5 to 5.9 compared to participants with BMI < 25 (34,38,41,48,52).…”

Section: [Insert Figures 2 and 3]mentioning

confidence: 99%

See 3 more Smart Citations

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

Torgbenu

Luckett

Buhagiar

et al. 2020

Preprint

View full text Add to dashboard Cite

Abstract Background Little is known about the prevalence and incidence in low and middle-income countries (LMICs) of secondary lymphedema due to cancer. This study aims to estimate the prevalence and incidence in LMICs of secondary lymphedema related to cancer and/or its treatment(s) and identify risk factors. Method A systematic review and meta-analysis was conducted. Medline, EMBASE and CINAHL were searched in June 2019 for peer-reviewed articles that assessed prevalence and/or incidence of cancer-related lymphedema in LMICs. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Estimates of pooled prevalence and incidence estimates were calculated with 95% confidence intervals (CI), with sub-group analyses grouping studies according to: country of origin, study design, risk of bias, setting, treatment, and lymphedema site and measurement. Heterogeneity was measured using X ² and I 2 , with interpretation guided by the Cochrane Handbook for Systematic Reviews. Results Of 8766 articles, 36 were included. Most reported on arm lymphedema secondary to breast cancer treatment (n=31), with the remainder reporting on leg lymphedema following gynecological cancer treatment (n=5). Arm lymphedema was mostly measured by arm circumference (n=16/31 studies), and leg lymphedema through self-report (n=3/5 studies). Eight studies used more than one lymphedema measurement. Only two studies that measured prevalence of leg lymphedema could be included in a meta-analysis (pooled prevalence =10.0%, 95%CI 7.0 – 13.0, I 2 =0%). The pooled prevalence of arm lymphedema was 27%, with considerable heterogeneity (95%CI 20.0 – 34.0, I 2 =94.69%, n =13 studies). The pooled incidence for arm lymphedema was 21%, also with considerable heterogeneity (95%CI 15.0 – 26.0, I 2 =95.29%, n =11 studies). There was evidence that higher BMI (>25) was associated with increased risk of arm lymphedema (OR: 1.98, 95%CI 1.45 – 2.70, I 2 =84.0%, P< 0.0001, n =4 studies). Conclusion Better understanding the factors that contribute to variability in cancer-related arm lymphedema in LMICs is an important first step to developing targeted interventions to improve quality of life. Standardising measurement of lymphedema globally and better reporting would enable comparison within the context of information about cancer treatments and lymphedema care.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Synthesis Arm Lymphedema Following Breast Cancer Treatmentmentioning

confidence: 99%

Section: [Insert Figures 2 and 3]mentioning

confidence: 99%

Section: [Insert Figures 2 and 3]mentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

Torgbenu

Luckett

Buhagiar

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Bu dönemde Eş'arîler genel olarak Tanrı'nın bilgisine ulaşmada akıl yürütmeyi, dinsel doğrulamaya tercih etmişlerdir. 60 Eş'arîlerin bütün bu aklileştirme gayretleri geleneksel literal bakış açısına sahip olanlarca hoş karşılanmamıştır. 61 5.…”

Section: Akıl-nakil İlişkisinin Kelam Tarihindeki Geçmişiunclassified

İbn-İ Fûrek Te Akil-Naki̇l İli̇şki̇si̇

Bardak¹

2017

jisr

View full text Add to dashboard Cite

ÖzAkıl-nakil konusu İslam kelam ekollerinde sürekli olarak tartışılagelmiştir. Kelamcıların aklı ön plana çıkararak ondan yana tavır aldıkları bilinmektedir. Fakat naklin de kelam ilminde mutlak bir yeri ve önemi bulunmaktadır. Selefiye ve diğer nakilcilerin şiddetli tenkidine maruz kalmış olan kelamcıların konu hakkındaki görüşlerini ve kendilerini savundukları argümanların bilinmesi gerekir. Konu hakkında görüşlerini ele alacağımız İbn Fûrek, Eş'ariliğin sistemleşmesinde önemli bir yere sahip kelamcıdır. O, İmam Eş'arî'nin eserlerinin günümüze intikal etmesinde büyük bir çaba göstermiştir. Kendisi de Eş'arî mezhebine mensup olan İbn Fûrek'in akıl-nakil tartışması için söylediği görüşleri Eş'ariliğin konuya bakışını yansıtması bakımından önem arz etmektedir.Anahtar Kelimeler: Akıl, Nakil, İbn Fûrek, Kelam, Eş'arilik. AbstractThe mind-carrying subject has been constantly discussed in the schools of Islamic kalam. It is known that theologians acted in favor of him by making a clear frontal plan. However, there is an absolute place and precaution of conveying, in the translation. Shalafies and other transporters should be aware of the views of the theologians who have been exposed to severe arguments they defend themselves. Ibn Fûrek, who will discuss his views on the subject, is a kelam with an important place in the systemization of Ash'arism. He has made a great effort in the passing of the works of Imam Ash'ari to the day-to-day. It is also important for Ibn Fûrek, who belongs to the Ash'arite sect, to express his views on the reasoning debate, thus reflecting the views of Ash'arism.

show abstract

The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements

Shah

Zambelli-Weiner

Delgado

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

Background Chronic breast cancer-related lymphedema (BCRL) is a potentially serious complication following treatment. Monitoring for progression to BCRL may allow for earlier detection and intervention, reducing the rate of progression to chronic BCRL. Therefore, the purpose of this meta-analysis is to evaluate the impact of monitoring techniques on the incidence of chronic BCRL among patients monitored by bioimpedance spectroscopy (BIS) and circumference as compared to background rates. Methods Eligible peer-reviewed studies from PubMed, CINHAL, or Google Scholar that were published in English from 2013 onward and conducted in North America, Europe, or Oceania. Incidence rates abstracted from studies were classified by BCRL monitoring method: background (no standardized BIS or circumference assessments), BIS or circumference. A random-effects model was used to calculate a pooled annualized estimate of BCRL incidence while accounting for clinical and methodological heterogeneity. Subgroup analyses examined differences in duration of follow-up as well as breast and axillary surgery. Results 50 studies were included, representing over 67,000 women. The annualized incidence of BCRL was 4.9% (95% CI: 4.3–5.5) for background studies (n = 35), 1.5% (95% CI: 0.6–2.4) for BIS-monitored studies (n = 7), and 7.7% (95% CI: 5.6–9.8) for circumference-monitored studies (n = 11). The cumulative BCRL incidence rate in BIS-monitored patients was 3.1% as compared to 12.9% with background monitoring (69% reduction) and 17.0% with circumference-monitored patients (81% reduction). Conclusions Evidence suggests that monitoring with BIS allowing for early intervention significantly reduces the relative risk of chronic BCRL with a 69% and 81% reduction compared to background and circumference, respectively. Circumference monitoring did not appear to provide a benefit with respect to chronic BCRL incidence. Based on these results, BIS should be considered for BCRL screening in order to detect subclinical BCRL and reduce rates of chronic BCRL, particularly in high-risk patients.

show abstract

Lymphoedema after mastectomy for breast cancer: Importance of supportive care

Cited by 5 publications

References 17 publications

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

İbn-İ Fûrek Te Akil-Naki̇l İli̇şki̇si̇

The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements

Contact Info

Product

Resources

About